Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Latin Times
Latin Times
M.B. Mack

Blue Cross Appears to Blame Patient with Lethal Disease for Picking the Wrong Plan After Denying Her Life-Saving Drug: 'I'm Not a Dumb Person'

A Kansas City medical student battling a life-threatening autoimmune disease has been denied coverage for a critical medication by Blue Cross, which is blaming her for choosing the wrong plan.

Kaitlyn Sy, a KU medical student, was diagnosed three years ago with an autoimmune disease that prevents her blood from clotting, leaving her at constant risk of fatal internal bleeding, according to Fox4KC.

After exhausting other treatments, her doctor prescribed Promacta, a medication that could stabilize her condition. However, when Sy went to fill the prescription, her insurance company denied coverage, citing her plan's limitations.

Sy, who had to pause her medical studies due to her deteriorating health, now faces an $8,000 monthly bill for the medication.

Her appeals to Blue Cross and Blue Shield of Kansas City have been rejected, with the company stating that her plan does not cover the drug.

"Before signing up for any health insurance plan, we encourage consumers to work with their human resource departments or an insurance broker to ensure the plan they are considering will meet their needs," the provider wrote in a statement.

Sy's condition has worsened, and she has turned to social media to share her story, which has gone viral. Meanwhile, Sy is considering legal options to challenge the denial.

"I would like to think as a medical student, I'm not a dumb person, but if my insurance card says preferred card blue, what plan do you think I'd be on," Sy said.

Health insurance coverage has become a hot topic since the shooting death of UnitedHealthcare CEO Brian Thompson last week in Manhattan. Prime suspect Luigi Mangione is in custody for the apparent act of payback against the industry.

© 2024 Latin Times. All rights reserved. Do not reproduce without permission.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.